Inflammation and myeloid malignancy: quenching the flame

Area of Science:

• Hematology and Oncology
• Immunology
• Aging Research

Background:

• Chronic inflammation associated with aging (inflammaging) is a key factor in myeloid malignancy development.
• Inflammatory activity impacts various bone marrow cells, including normal hematopoietic cells, stromal cells, and leukemic cells.

Purpose of the Study:

• To review the complex roles of inflammation in the pathogenesis of myeloid malignancies.
• To differentiate between cell-intrinsic and extrinsic inflammatory effects.
• To inform the design of future clinical trials targeting inflammation in these cancers.

Main Methods:

• Review of existing literature on chronic inflammation, aging, and myeloid malignancies.
• Analysis of how inflammation differentially affects normal and malignant hematopoietic cells.
• Conceptual framework separating cell-intrinsic versus extrinsic inflammatory mechanisms.

Main Results:

• Inflammation promotes selective clonal expansion of leukemic cells.
• Immune-mediated suppression differentially impacts normal hematopoietic cells and malignant clones.
• Distinct effects of aberrant inflammatory activity on various bone marrow components are observed.

Conclusions:

• Inflammaging is a critical driver in myeloid malignancies.
• Distinguishing cell-intrinsic and extrinsic inflammatory roles is crucial for understanding disease progression.
• This understanding provides a basis for developing novel therapeutic strategies in clinical trials.